1 | the inner ear is | | | | | | | 2 | 0.20% |
2 | is very detailed it | | | | | | | 2 | 0.20% |
3 | it results from a | | | | | | | 2 | 0.20% |
4 | positional vertigo vestibular neuritis | | | | | | | 2 | 0.20% |
5 | arnoldchiari malformation vestibular migraines | | | | | | | 1 | 0.10% |
6 | malformation vestibular migraines | | | | | | | 1 | 0.10% |
7 | vestibular migraines 5 a | | | | | | | 1 | 0.10% |
8 | migraines 5 a therapeutic | | | | | | | 1 | 0.10% |
9 | approach to different pathologies | | | | | | | 1 | 0.10% |
10 | to different pathologies | | | | | | | 1 | 0.10% |
11 | different pathologies surgical | | | | | | | 1 | 0.10% |
12 | pathologies surgical or | | | | | | | 1 | 0.10% |
13 | surgical or gamma | | | | | | | 1 | 0.10% |
14 | surgical or gamma knife | | | | | | | 1 | 0.10% |
15 | or gamma knife treatment | | | | | | | 1 | 0.10% |
16 | for vestibular schwannoma intratympanic | | | | | | | 1 | 0.10% |
17 | vestibular schwannoma intratympanic gentamicin | | | | | | | 1 | 0.10% |
18 | schwannoma intratympanic gentamicin injections | | | | | | | 1 | 0.10% |
19 | intratympanic gentamicin injections to | | | | | | | 1 | 0.10% |
20 | suppress vertiginous conditions in | | | | | | | 1 | 0.10% |
21 | vertiginous conditions in ménieres | | | | | | | 1 | 0.10% |
22 | conditions in ménieres disease | | | | | | | 1 | 0.10% |
23 | in ménieres disease treatment | | | | | | | 1 | 0.10% |
24 | ménieres disease treatment of | | | | | | | 1 | 0.10% |
25 | superior canal dehiscence syndrome | | | | | | | 1 | 0.10% |
26 | or superior canal dehiscence | | | | | | | 1 | 0.10% |
27 | vertigo by therapeutic epley | | | | | | | 1 | 0.10% |
28 | different types of peripheral | | | | | | | 1 | 0.10% |
29 | the otolithic saccular and | | | | | | | 1 | 0.10% |
30 | otolithic saccular and utricular | | | | | | | 1 | 0.10% |
31 | saccular and utricular receptors | | | | | | | 1 | 0.10% |
32 | and utricular receptors | | | | | | | 1 | 0.10% |
33 | utricular receptors 4 a | | | | | | | 1 | 0.10% |
34 | receptors 4 a semantic | | | | | | | 1 | 0.10% |
35 | approach for patients with | | | | | | | 1 | 0.10% |
36 | for patients with different | | | | | | | 1 | 0.10% |
37 | patients with different types | | | | | | | 1 | 0.10% |
38 | with different types of | | | | | | | 1 | 0.10% |
39 | types of peripheral vertigo | | | | | | | 1 | 0.10% |
40 | syndrome or superior canal | | | | | | | 1 | 0.10% |